It’s clear to me how Dr. Perin would have had a strong influence on the agenda, that being promoting cell therapy as a breakthrough . I just wish that Dr. Rose might eventually fill the last speaking spot, and that it would be just after FDA agreed with the company a pathway for both LVAD and HLHS approval.
Cell Therapy News/Articles, page-17679
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
-0.020(2.01%) |
Mkt cap ! $1.124B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 97.0¢ | $881.0K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 137827 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 31915 | 19 |
View Market Depth
| Last trade - 12.38pm 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |